← Leaderboards
William L Rumsey
Luciole Pharmaceuticals, Inc.
$501,626
Attributed
$501,626
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $303.5K · FY2023–24$500K$375K$250K$125K$0
'23
'24
Funding mix
By agency
NIH$501,626 · 1
By mechanism
R43$501,626 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAffectAmyloidAcetylcholinesteraseAllosteric SiteBiological MarkersAdultApp-Ps1Base Excision RepairsBindingBioenergeticsBiologicalCessation Of LifeBlood-Brain Barrier PenetrationBrainBrain DiseasesCandidate SelectionCause Of DeathCell DeathCell Death InductionCell NucleusCellsCell SurvivalChemistry
Grant awards (2)
Discovery and development of OGG1 activators as precision drugs for modification of Alzheimer's disease progression.$198,117
R43 · FY2024 · AG · contact PI
Discovery and development of OGG1 activators as precision drugs for modification of Alzheimer's disease progression.$303,509
R43 · FY2023 · AG · contact PI